关于在怀孕期糖尿病患者中进行血糖管理的运动治疗的最新发现
Ah Reum Jung1, Yongsuk Seo1, Jooyoung Lee1
1Exercise Physiology Laboratory, Kookmin University, Seoul 02707, Republic of Korea.
Journal of clinical medicine
|September 14, 2024
概括
管理妊娠糖尿病 (GDM) 需要仔细控制血糖. 本综述综合了GDM的运动指南,强调需要对安全的体育活动协议进行更多研究.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 运动医学 运动医学
背景情况:
- 孕期糖尿病 (GDM) 管理对于母亲和胎儿的健康至关重要.
- 在GDM中血糖控制不足会增加母亲和胎儿的风险.
研究的目的:
- 来自主要专业协会的GDM患者的现有运动治疗指南的整合.
- 识别GDM实践管理的基于证据的建议中的差距.
- 建议未来的研究方向,以优化GDM练习协议.
主要方法:
- 系统审查来自知名组织 (ACOG,SOGC,CSEP,ACSM,ADA,KDA) 的最新运动指南.
- 分析推的运动频率,强度,持续时间和类型.
- 确定GDM练习的禁忌和具体预防措施.
主要成果:
- 大多数指导方针建议每周3至4次进行150分钟的低至中等强度有氧和抵抗运动.
- 通常建议不要进行突然改变方向的活动,身体接触,跌倒风险或仰卧姿势.
- 在GDM运动期间管理血糖波动的具体,基于证据的建议方面存在重大差距.
结论:
- 目前的指导方针为GDM提供了一般的运动建议,但缺乏在活动期间控制血糖的具体方案.
- 为了为GDM患者制定定制的,基于证据的炼指南,进一步的研究是必不可少的.
- 加强的研究将提高运动在管理GDM和减轻不良结果的安全性和有效性.
更多相关视频
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
1.1K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
210
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Pathophysiology of Diabetes
906
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
906
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Hypoglycemia and Glucagon
216
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
216
